PAIN THERAPEUTICS Aktie

3,03 EUR 3,7367%

Zu Ihrem Onlinebroker

kaufen verkaufen

PAIN THERAPEUTICS Aktienkurs : 25.05. ( 15 Min. verzögert)
3,03 € Letzter Kurs	3,74% Veränderung	2,92 € Vortag	3,03 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
3,03 - 3,03 Tag	6,91 - 2,40 52 Wochen	0 Tag	98 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

PAIN THERAPEUTICS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

24.05.

DURECT Corporation (DRRX) Ready to Pop Thanks to Help from Pfizer (PFE), Pain ...

More than that, now that the dust is settling on the company's complicated partnership with Pfizer (NYSE:PFE) and Pain Therapeutics (NASDAQ:PTIE), odds are good today's smallish advance could actually be an omen of a much bigger move; ...
23.05.

Opioid Painkillers Try to Please their Patients

Current competition between chronic pain therapeutics is strong, as many treatment options for chronic pain are available, meaning that lower market potential is available for any...

15.05.

Hear from industry experts at Pain Therapeutics 2012, taking place in 1 week's ...

Join SMi at the 12th annual Pain Therapeutics conference, which will be held on 21st & 22nd May 2012 in London, UK. /EINPresswire.com/ Pain is an incredibly hot...
09.05.

Transient receptor potential melastatin 8 (TRPM8) channels are involved in ...

Since TRPM8 has been considered as a potential target for chronic pain therapeutics, we have investigated the role of TRPM8 in Tb regulation. Results: We characterized five chemically distinct compounds (AMG0635, AMG2850, AMG8788,...
08.05.

Pain Therapeutics Reports Q1 2012 Financial Results

AUSTIN, Texas, May 8, 2012 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the quarter ended March 31, 2012. Net profit for Q1 2012 was $30000,...